Does the Biden administration prioritize diversity over scholarship in its cancer fight?
President Biden’s Quest to Cure Cancer
President Joe Biden’s mission to find a cure for cancer has garnered strong bipartisan support in Congress, making it one of the few policy aims that transcends party lines. This endeavor holds personal significance for Biden, who tragically lost his oldest son, Beau Biden, to brain cancer in 2015 at the age of 46.
In 2016, then-President Barack Obama signed the 21st Century Cures Act, which initiated the “cancer moonshot” and entrusted then-Vice President Joe Biden with its leadership during their remaining time in office. This program allocates $1.8 billion over seven years to combat cancer.
Setting Ambitious Goals
Biden set an ambitious goal during his 2019 campaign for the Democratic presidential nomination, vowing to “cure cancer.” However, since assuming office after defeating former President Donald Trump in 2020, the Biden administration has adjusted its expectations. The current objective is to reduce the death rate from cancer by 50% by 2045, with Biden now speaking of “ending cancer as we know it.”
While funding for cancer research is not lacking, with the National Cancer Institute having a budget of $6.4 billion and nonprofit organizations raising billions annually, the impact of an additional $1.8 billion over seven years is a subject of debate.
The Complexity of Cancer
Cancer is a complex disease that manifests differently in each patient. Each case, whether it be breast cancer, lung cancer, or liver cancer, possesses unique genetic characteristics, resulting in varying responses to treatments. Renowned oncologist Siddhartha Mukherjee describes tumors as a “genetic bedlam” with layers of mutations.
Allocating Funds for Research
The success of the cancer moonshot program hinges on how the allocated funds are utilized. As part of Biden’s “unity agenda,” the White House has designated $5.4 million for a “cohort of Cancer Moonshot Scholars.” This program aims to support early-career researchers and foster a diverse cancer research workforce that represents America’s diversity.
While the amount of money allocated may seem small in comparison to the federal budget, it invites criticism as the administration prioritizes diversity and equity over direct policy. Biden’s executive order on racial equity and support for underserved communities has already faced legal challenges.
Prevention and Treatment
Studies have shown that reducing cancer deaths is not solely reliant on improved treatments and new drugs. Emphasizing better day-to-day health practices, such as smoking cessation, healthier diets, weight loss, exercise, and reduced alcohol consumption, can significantly contribute to lowering cancer mortality rates. Additionally, expanding access to early detection methods like colonoscopies and mammograms plays a crucial role.
Keith Humphreys, a public health professor at Stanford University, emphasizes the importance of prevention, stating that it is always better to prevent a disease than to treat it.
It remains uncertain how much of the cancer moonshot funding will be allocated to preventive measures. The administration has mentioned prevention in its agenda, but the only concrete step taken thus far is the Food and Drug Administration’s proposal to ban the sale of menthol cigarettes.
Click here to read more from The Washington Examiner.
How does President Biden’s cancer initiative promote collaboration and data sharing among researchers, healthcare providers, and patients?
R, lung cancer, or brain cancer, presents unique challenges and requires tailored treatments. Researchers and scientists are constantly working to understand the underlying causes of cancer and develop effective treatments.
One of the key aspects of President Biden’s cancer initiative is promoting collaboration and data sharing among researchers, healthcare providers, and patients. By breaking down silos and encouraging collaboration, the hope is that progress can be accelerated, and breakthroughs can be achieved more quickly.
In addition to collaboration, the Biden administration is also focused on improving access to cancer care for all Americans. This includes addressing disparities in cancer outcomes among different populations, ensuring that everyone, regardless of their background or income, has access to high-quality care.
Another critical component of President Biden’s plan is investing in innovative technologies and research. This includes advancements in precision medicine, immunotherapy, and genomics, which have shown promising results in recent years. By investing in these areas, the administration aims to provide patients with more targeted and effective treatments.
While the goal of “curing” cancer may seem lofty, it is important to recognize the progress that has already been made. Improved screening methods, early detection techniques, and advancements in treatment options have led to significant improvements in cancer survival rates over the years.
President Biden’s quest to cure cancer is not only a personal mission for him but also a national priority. By focusing on collaboration, access to care, and innovation, the administration hopes to make significant strides in the fight against cancer. While finding a cure may still be a long way off, the determination and bipartisan support behind this effort give hope to millions of individuals and families affected by cancer.
In conclusion, President Biden’s mission to find a cure for cancer is an ambitious endeavor that has garnered strong bipartisan support. With a focus on collaboration, access to care, and innovation, the administration aims to reduce the death rate from cancer by 50% by 2045. While the complexity of cancer poses challenges, the progress made in recent years and the dedication behind this initiative give hope for a future where cancer can be eradicated.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...